Larimar Therapeutics, Inc.(LRMR)

Biotechnology · Bala Cynwyd, PA

$2.87+0.01 (+0.17%)

Delayed quote: Oct 6, 2026, 11:50 AM EDT

Larimar Therapeutics (LRMR) EV/FCF: History & Chart | TGMCharts

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T15:52:03.587Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:52:03.587Z.

Quote observation: 2026-10-06T15:50:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 297,624,795
Total debt · period ending 2026-06-30: 4,956,000
Cash · period ending 2026-06-30: 92,687,000
TTM free cash flow: N/A

FMP input reference: 820e6844a86ebcce87b4cbc727545bf8fd5f2e7882f78b89935f6b0fc3bd738c

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LRMR EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

LRMR Competitors' EV/FCF Ratio

LRMR

Larimar Therapeutics, Inc.

Current

Market Cap

$297.62M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BNTC

Benitec Biopharma Inc.

vs LRMR

Market Cap

$303.05M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LAB

Standard BioTools Inc.

vs LRMR

Market Cap

$290.74M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBOT

BridgeBio Oncology Therapeutics Inc.

vs LRMR

Market Cap

$290.91M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ABEO

Abeona Therapeutics Inc.

vs LRMR

Market Cap

$288.87M

EV/FCF Ratio

N/A

TTM Avg

37.98x

3Y Avg

37.98x

5Y Avg

37.98x

INDP

Indaptus Therapeutics, Inc.

vs LRMR

Market Cap

$283.42M

EV/FCF Ratio

N/A

TTM Avg

1.69x

3Y Avg

1.69x

5Y Avg

1.69x

MOBI

Mobia Medical, Inc. Common Stock

vs LRMR

Market Cap

$308.55M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FULC

Fulcrum Therapeutics, Inc.

vs LRMR

Market Cap

$283.92M

EV/FCF Ratio

N/A

TTM Avg

52.46x

3Y Avg

52.46x

5Y Avg

52.46x

ACB

Aurora Cannabis Inc.

vs LRMR

Market Cap

$280.60M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FATE

Fate Therapeutics, Inc.

vs LRMR

Market Cap

$279.16M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Larimar Therapeutics, Inc. (LRMR)	$297.62M	N/A	N/A	N/A	N/A
Benitec Biopharma Inc. (BNTC)vs ›	$303.05M	N/A	N/A	N/A	N/A
Standard BioTools Inc. (LAB)vs ›	$290.74M	N/A	N/A	N/A	N/A
BridgeBio Oncology Therapeutics Inc. (BBOT)vs ›	$290.91M	N/A	N/A	N/A	N/A
Abeona Therapeutics Inc. (ABEO)vs ›	$288.87M	N/A	37.98x	37.98x	37.98x
Indaptus Therapeutics, Inc. (INDP)vs ›	$283.42M	N/A	1.69x	1.69x	1.69x
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$308.55M	N/A	N/A	N/A	N/A
Fulcrum Therapeutics, Inc. (FULC)vs ›	$283.92M	N/A	52.46x	52.46x	52.46x
Aurora Cannabis Inc. (ACB)vs ›	$280.60M	N/A	N/A	N/A	N/A
Fate Therapeutics, Inc. (FATE)vs ›	$279.16M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

LRMR EV/FCF Ratio Metrics

LRMR Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics